Compile Data Set for Download or QSAR
Report error Found 109 Enz. Inhib. hit(s) with all data for entry = 11397
TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 611952BDBM611952(US11718618, Compound 4-119 | (2R,3R,11bR)-9- (cycl...)
Affinity DataKi:  0.290nMAssay Description:The human VMAT2 Ki values for the compounds listed in Table 15A and Table 15B were determined using the following procedures. Compound dilution serie...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 611939BDBM611939(US11718618, Compound 4-90 | (2R,3R,11bR)-3-(2,2- d...)
Affinity DataKi:  0.290nMAssay Description:The human VMAT2 Ki values for the compounds listed in Table 15A and Table 15B were determined using the following procedures. Compound dilution serie...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 611867BDBM611867(US11718618, Compound 4-23 | 1-(2-{[(2R,3R,11bR)-3-...)
Affinity DataKi:  0.410nMAssay Description:The human VMAT2 Ki values for the compounds listed in Table 15A and Table 15B were determined using the following procedures. Compound dilution serie...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 611873BDBM611873(US11718618, Compound 4-28 | (2R,3R,11bR)-3-(2,2- d...)
Affinity DataKi:  0.480nMAssay Description:The human VMAT2 Ki values for the compounds listed in Table 15A and Table 15B were determined using the following procedures. Compound dilution serie...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 611905BDBM611905(US11718618, Compound 4-56 | (2R,3R,11bR)-3-(2,2- d...)
Affinity DataKi:  0.520nMAssay Description:The human VMAT2 Ki values for the compounds listed in Table 15A and Table 15B were determined using the following procedures. Compound dilution serie...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 611877BDBM611877(US11718618, Compound 4-32 | (2R,3R,11bR)-9-cyclobu...)
Affinity DataKi:  0.590nMAssay Description:The human VMAT2 Ki values for the compounds listed in Table 15A and Table 15B were determined using the following procedures. Compound dilution serie...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 611937BDBM611937(US11718618, Compound 4-88 | (2R,3R,11bR)-9- (cyclo...)
Affinity DataKi:  0.680nMAssay Description:The human VMAT2 Ki values for the compounds listed in Table 15A and Table 15B were determined using the following procedures. Compound dilution serie...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 611954BDBM611954(US11718618, Compound 4-121 | (2R,3R,11bR)-9-[(2,2-...)
Affinity DataKi:  0.820nMAssay Description:The human VMAT2 Ki values for the compounds listed in Table 15A and Table 15B were determined using the following procedures. Compound dilution serie...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 611906BDBM611906(US11718618, Compound 4-57 | (2R,3R,11bR)-9-{[1- (d...)
Affinity DataKi:  0.930nMAssay Description:The human VMAT2 Ki values for the compounds listed in Table 15A and Table 15B were determined using the following procedures. Compound dilution serie...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 611872BDBM611872(US11718618, Compound 4-27 | (2R,3R,11bR)-9-cyclopr...)
Affinity DataKi:  1nMAssay Description:The human VMAT2 Ki values for the compounds listed in Table 15A and Table 15B were determined using the following procedures. Compound dilution serie...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 611858BDBM611858((2R,3R,11bR)-3-(2,2- dimethylpropyl)-9-ethoxy-10- ...)
Affinity DataKi:  1.10nMAssay Description:The human VMAT2 Ki values for the compounds listed in Table 15A and Table 15B were determined using the following procedures. Compound dilution serie...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 611856BDBM611856(US11718618, Compound 4-15 | (2R,3R,11bR)-3-(2,2- d...)
Affinity DataKi:  1.10nMAssay Description:The human VMAT2 Ki values for the compounds listed in Table 15A and Table 15B were determined using the following procedures. Compound dilution serie...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 611900BDBM611900(US11718618, Compound 4-55 | (2R,3R,11bR)-3-(2,2- d...)
Affinity DataKi:  1.10nMAssay Description:The human VMAT2 Ki values for the compounds listed in Table 15A and Table 15B were determined using the following procedures. Compound dilution serie...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 611895BDBM611895(US11718618, Compound 4-50 | (2R,3R,11bR)-3-(2,2- d...)
Affinity DataKi:  1.40nMAssay Description:The human VMAT2 Ki values for the compounds listed in Table 15A and Table 15B were determined using the following procedures. Compound dilution serie...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 611858BDBM611858((2R,3R,11bR)-3-(2,2- dimethylpropyl)-9-ethoxy-10- ...)
Affinity DataKi:  1.40nMAssay Description:The human VMAT2 Ki values for the compounds listed in Table 15A and Table 15B were determined using the following procedures. Compound dilution serie...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 611953BDBM611953(US11718618, Compound 4-120 | (2R,3R,11bR)-3-(2,2- ...)
Affinity DataKi:  1.5nMAssay Description:The human VMAT2 Ki values for the compounds listed in Table 15A and Table 15B were determined using the following procedures. Compound dilution serie...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 611908BDBM611908(US11718618, Compound 4-59 | 5-({[(2R,3R,11bR)-3-(2...)
Affinity DataKi:  1.5nMAssay Description:The human VMAT2 Ki values for the compounds listed in Table 15A and Table 15B were determined using the following procedures. Compound dilution serie...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 611876BDBM611876(US11718618, Compound 4-31 | (2R,3R,11bR)-3-(2,2- d...)
Affinity DataKi:  1.60nMAssay Description:The human VMAT2 Ki values for the compounds listed in Table 15A and Table 15B were determined using the following procedures. Compound dilution serie...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 611950BDBM611950(US11718618, Compound 4-117 | (2R,3R,11bR)-3-(2,2- ...)
Affinity DataKi:  2.20nMAssay Description:The human VMAT2 Ki values for the compounds listed in Table 15A and Table 15B were determined using the following procedures. Compound dilution serie...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 611854BDBM611854(US11718618, Compound 4-13 | (2R,3R,11bR)-9-(2,2- d...)
Affinity DataKi:  2.20nMAssay Description:The human VMAT2 Ki values for the compounds listed in Table 15A and Table 15B were determined using the following procedures. Compound dilution serie...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 611889BDBM611889(US11718618, Compound 4-44 | 2-(2-{[(2R,3R,11bR)-3-...)
Affinity DataKi:  2.40nMAssay Description:The human VMAT2 Ki values for the compounds listed in Table 15A and Table 15B were determined using the following procedures. Compound dilution serie...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 611842BDBM611842(US11718618, Compound 4-1 | (2R,3R,11bR)-3-(2,2- di...)
Affinity DataKi:  2.40nMAssay Description:The human VMAT2 Ki values for the compounds listed in Table 15A and Table 15B were determined using the following procedures. Compound dilution serie...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 611897BDBM611897((2R,3R,11bR)-3-(2,2- dimethylpropyl)-9-(methoxy- d...)
Affinity DataKi:  2.5nMAssay Description:The human VMAT2 Ki values for the compounds listed in Table 15A and Table 15B were determined using the following procedures. Compound dilution serie...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 611855BDBM611855(US11718618, Compound 4-14 | (2R,3R,11bR)-9-(2,2- d...)
Affinity DataKi:  2.60nMAssay Description:The human VMAT2 Ki values for the compounds listed in Table 15A and Table 15B were determined using the following procedures. Compound dilution serie...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 611909BDBM611909(US11718618, Compound 4-60 | (2R,3R,11bR)-9-(benzyl...)
Affinity DataKi:  3.10nMAssay Description:The human VMAT2 Ki values for the compounds listed in Table 15A and Table 15B were determined using the following procedures. Compound dilution serie...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 611853BDBM611853(US11718618, Compound 4-12 | (2S,3R,11bR)-3-(2,2- d...)
Affinity DataKi:  3.40nMAssay Description:The human VMAT2 Ki values for the compounds listed in Table 15A and Table 15B were determined using the following procedures. Compound dilution serie...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 611910BDBM611910(US11718618, Compound 4-61 | (2R,3R,11bR)-3-(2,2- d...)
Affinity DataKi:  3.5nMAssay Description:The human VMAT2 Ki values for the compounds listed in Table 15A and Table 15B were determined using the following procedures. Compound dilution serie...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 611911BDBM611911(US11718618, Compound 4-62 | (2R,3R,11bR)-3-(2,2- d...)
Affinity DataKi:  3.70nMAssay Description:The human VMAT2 Ki values for the compounds listed in Table 15A and Table 15B were determined using the following procedures. Compound dilution serie...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 611883BDBM611883(US11718618, Compound 4-38 | (2R,3R,11bR)-3-(2,2- d...)
Affinity DataKi:  3.70nMAssay Description:The human VMAT2 Ki values for the compounds listed in Table 15A and Table 15B were determined using the following procedures. Compound dilution serie...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 611912BDBM611912(US11718618, Compound 4-63 | (2R,3R,11bR)-3-(2,2- d...)
Affinity DataKi:  4.20nMAssay Description:The human VMAT2 Ki values for the compounds listed in Table 15A and Table 15B were determined using the following procedures. Compound dilution serie...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 611900BDBM611900(US11718618, Compound 4-55 | (2R,3R,11bR)-3-(2,2- d...)
Affinity DataKi:  4.80nMAssay Description:The human VMAT2 Ki values for the compounds listed in Table 15A and Table 15B were determined using the following procedures. Compound dilution serie...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 611888BDBM611888(US11718618, Compound 4-43 | 2-(2-{[(2R,3R,11bR)-3-...)
Affinity DataKi:  4.80nMAssay Description:The human VMAT2 Ki values for the compounds listed in Table 15A and Table 15B were determined using the following procedures. Compound dilution serie...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 611913BDBM611913(US11718618, Compound 4-64 | (2R,3R,11bR)-3-(2,2- d...)
Affinity DataKi:  5.5nMAssay Description:The human VMAT2 Ki values for the compounds listed in Table 15A and Table 15B were determined using the following procedures. Compound dilution serie...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 611860BDBM611860(US11718618, Compound 4-18 | (2R,3R,11bR)-3-(2,2- d...)
Affinity DataKi:  5.5nMAssay Description:The human VMAT2 Ki values for the compounds listed in Table 15A and Table 15B were determined using the following procedures. Compound dilution serie...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 611869BDBM611869(US11718618, Compound 4-25 | (2R,3R,11bR)-3-(2,2- d...)
Affinity DataKi:  5.5nMAssay Description:The human VMAT2 Ki values for the compounds listed in Table 15A and Table 15B were determined using the following procedures. Compound dilution serie...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 611948BDBM611948(US11718618, Compound 4-115 | (2R,3R,11bR)-3-(2,2- ...)
Affinity DataKi:  6.10nMAssay Description:The human VMAT2 Ki values for the compounds listed in Table 15A and Table 15B were determined using the following procedures. Compound dilution serie...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 611897BDBM611897((2R,3R,11bR)-3-(2,2- dimethylpropyl)-9-(methoxy- d...)
Affinity DataKi:  6.60nMAssay Description:The human VMAT2 Ki values for the compounds listed in Table 15A and Table 15B were determined using the following procedures. Compound dilution serie...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 611890BDBM611890(US11718618, Compound 4-45 | 1-(2-{[(2R,3R,11bR)-3-...)
Affinity DataKi:  7.30nMAssay Description:The human VMAT2 Ki values for the compounds listed in Table 15A and Table 15B were determined using the following procedures. Compound dilution serie...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 611861BDBM611861(US11718618, Compound 4-19 | (2R,3R,11bR)-3-(2,2- d...)
Affinity DataKi:  8.10nMAssay Description:The human VMAT2 Ki values for the compounds listed in Table 15A and Table 15B were determined using the following procedures. Compound dilution serie...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 611914BDBM611914(US11718618, Compound 4-65 | (2R,3R,11bR)-9-(2-chlo...)
Affinity DataKi:  8.70nMAssay Description:The human VMAT2 Ki values for the compounds listed in Table 15A and Table 15B were determined using the following procedures. Compound dilution serie...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 611896BDBM611896(US11718618, Compound 4-51 | (2R,3R,11bR)-9-(3,3-di...)
Affinity DataKi:  9.40nMAssay Description:The human VMAT2 Ki values for the compounds listed in Table 15A and Table 15B were determined using the following procedures. Compound dilution serie...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 611915BDBM611915(US11718618, Compound 4-66 | (2R,3R,11bR)-3-(2,2- d...)
Affinity DataKi:  10nMAssay Description:The human VMAT2 Ki values for the compounds listed in Table 15A and Table 15B were determined using the following procedures. Compound dilution serie...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 611898BDBM611898(US11718618, Compound 4-53 | (2R,3R1bR)-3-(2,2- dim...)
Affinity DataKi:  12nMAssay Description:The human VMAT2 Ki values for the compounds listed in Table 15A and Table 15B were determined using the following procedures. Compound dilution serie...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 611884BDBM611884(US11718618, Compound 4-39 | (2R,3R,11bR)-3-(2,2- d...)
Affinity DataKi:  12nMAssay Description:The human VMAT2 Ki values for the compounds listed in Table 15A and Table 15B were determined using the following procedures. Compound dilution serie...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 611899BDBM611899(US11718618, Compound 4-54 | (2R,3R,11bR)-3-(2,2- d...)
Affinity DataKi:  12nMAssay Description:The human VMAT2 Ki values for the compounds listed in Table 15A and Table 15B were determined using the following procedures. Compound dilution serie...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 611875BDBM611875(US11718618, Compound 4-30 | (2R,3R,11bR)-3-(2,2- d...)
Affinity DataKi:  12nMAssay Description:The human VMAT2 Ki values for the compounds listed in Table 15A and Table 15B were determined using the following procedures. Compound dilution serie...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 611951BDBM611951(US11718618, Compound 4-118 | (2S,3R,11bR)-3-(2,2- ...)
Affinity DataKi:  13nMAssay Description:The human VMAT2 Ki values for the compounds listed in Table 15A and Table 15B were determined using the following procedures. Compound dilution serie...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 611916BDBM611916(US11718618, Compound 4-67 | (2R,3R,11bR)-3-(2,2- d...)
Affinity DataKi:  14nMAssay Description:The human VMAT2 Ki values for the compounds listed in Table 15A and Table 15B were determined using the following procedures. Compound dilution serie...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 611866BDBM611866(US11718618, Compound 4-22 | (2R,3R,11bR)-3-(2,2- d...)
Affinity DataKi:  14nMAssay Description:The human VMAT2 Ki values for the compounds listed in Table 15A and Table 15B were determined using the following procedures. Compound dilution serie...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

TargetSynaptic vesicular amine transporter(Human)
Neurocrine Biosciences

US Patent
LigandChemical structure of BindingDB Monomer ID 611852BDBM611852(US11718618, Compound 4-11 | (2S,3R,11bR)-9-(2,2- d...)
Affinity DataKi:  14nMAssay Description:The human VMAT2 Ki values for the compounds listed in Table 15A and Table 15B were determined using the following procedures. Compound dilution serie...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/17/2023
Entry Details
US Patent

Displayed 1 to 50 (of 109 total ) | Next | Last >>
Jump to: